11th July 2017 Content supplied by: Luminex Corporation
CE-IVD Mark for Luminex ARIES® Norovirus Assay from Stool Specimens
Luminex Corporation has received CE-IVD marking for the ARIES® Norovirus Assay, an easy to use, sample to answer test for rapid detection and differentiation of norovirus genogroup I and II from stool specimens of individuals with symptoms of acute gastroenteritis.
As the fifth CE-marked assay for use on Luminex's ARIES® Systems, the Norovirus Assay adds to a growing menu of tests for the ARIES® platform. The system is designed to run in multiple laboratory shifts and allows labs to simultaneously run both IVD and LDT assays in a sample to answer format when using a Universal Assay Protocol.
ARIES® Systems automate all aspects of testing, from sample preparation through analysis, providing answers in less than 2 hours with minimal hands-on time while enabling easy implementation on weekends and night shifts. The ARIES® Norovirus Assay, a real-time polymerase chain reaction (PCR)-based qualitative in vitro diagnostic test, is part of Luminex's comprehensive gastroenterological testing menu that also includes the xTAG® Gastrointestinal Pathogen Panel (GPP), VERIGENE® Enteric Pathogens Test (EP), and the ARIES® C. difficile Assay (RUO).
The ARIES® Norovirus Assay is intended to aid in the diagnosis of norovirus infections when used in conjunction with clinical evaluation, laboratory findings, and epidemiological information. The assay also aids in the detection and identification of norovirus infections in the context of outbreaks.
For more information, please visit www.luminexcorp.com/norovirus
Date Published: 11th July 2017
Source article link: http://investor.luminexcorp.com/phoenix.zhtml?c=79403&p=irol-newsArticle&ID=2283602
Boehringer Ingelheim Selects Novatek for
Inlabtec Serial Diluter Chosen by